Search

everythinglearnresearchcommunity

for

Search:↓

Astilbin can potentially calm overactive immune responses, like in Type 1 Diabetes, by suppressing certain cell activities and reducing inflammation.

Using healthy donor stem cells can potentially calm overactive immune cells and reduce inflammation in severe hair loss patients, offering a possible treatment method.

Diphenylcyclopropenone (DPCP) is more effective than anthralin for treating resistant alopecia areata.

Tofacitinib, an arthritis drug, helped hair growth in alopecia universalis but long-term safety needs more research.

Azathioprine can cause unusual hair loss, which may reverse after stopping the drug.

Expanding regulatory T cells may help treat alopecia areata by reducing harmful immune cells.

Combining high-dose corticosteroids with methotrexate may be effective and safe for severe alopecia areata.

Tacrolimus is a better option than cyclosporine due to fewer side effects.

The combined treatment helps improve severe hair loss and reduces the need for other medications.

A Labrador Retriever with pemphigus fully recovered after six weeks of azathioprine treatment.

Lenalidomide effectively and safely treats skin symptoms in pediatric lupus, reducing the need for prednisone.

Infliximab can cause SAPHO syndrome, which may improve with Spesolimab and methotrexate.

Baricitinib is effective and safe for treating severe alopecia areata.

Timely diagnosis and aggressive treatment with high-dose steroids and B-cell depletion therapies are effective for severe acute cutaneous lupus.

MDSC-Exo can treat autoimmune alopecia areata and promote hair regrowth in mice.

Early treatment with JAK inhibitors leads to better hair regrowth in acute alopecia areata.

Zinc supplements effectively treat acrodermatitis enteropathica.

Cyproterone acetate implants were more effective at reducing facial hair and improving skin in severe hirsutism than oral treatment.

Acitretin helped improve hand mobility and skin condition in a patient.

A patient with lupus and long-term hair loss saw significant hair regrowth after using the drug tofacitinib.

Targeting specific metabolic and ionic pathways may improve alopecia areata treatment.

A girl with a rare skin condition improved after one month of treatment with acitretin.

Alopecia areata can be reversed by JAK inhibitors, promoting hair regrowth.

The conclusion is that a new method could improve the identification of autoimmune targets in alopecia areata, despite some limitations.

A new method allows for controlled, long-lasting delivery of retinoic acid through the skin with fewer side effects.

Ocrelizumab may cause pancreatitis in some patients.

Baricitinib showed mixed results in treating alopecia areata in children, with some improvement but also side effects.

DM and AA may share a common cause.

Baricitinib is a safe and effective treatment for alopecia areata, with better results in patients with lower initial severity, shorter disease duration, and longer treatment.

A woman with alopecia regrew her hair after taking a higher dose of tocilizumab.